Answers are grounded in this paper and cite their sources.
A calcium channel blocker called lercanidipine shows promise as a treatment for hypertension, especially in older people. Exhibiting greater effectiveness in comparison to other calcium channel blockers, it presents encouraging opportunities for the management of hypertension. Its use has a low risk to renal function, which sets it apart from other medicines in its class that might have a negative impact on the kidneys. Consequently, lercanidipine distinguishes itself as a beneficial and well-tolerated treatment choice for hypertension patients, providing a possible way to address cardiovascular issues without jeopardizing renal function, particularly in the elderly population.
No takes yet. Share an insight, caveat, or question.
Darshan Sharad Sonawane (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: